| Accession Number: | 0001209191-20-011041 |
| Date: | 2020-02-18 |
| Issuer: | DECIPHERA PHARMACEUTICALS, INC. (DCPH) |
| Original Submission Date: |
SHERMAN MATTHEW L
C/O DECIPHERA PHARMACEUTICALS, INC.
200 SMITH STREET
WALTHAM, MA 02451
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2020-02-18 | A | 1,760 | a | $0.00 | 36,760 | direct |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| STOCK OPTION (RIGHT TO BUY) | 54.87 | 2020-02-18 | deemed execution date | A | 10,520 (d) | 2030-02-17 | common stock 10,520 | $54.87 | 10,520 | direct |
| ID | footnote |
|---|---|
| f1 | the reporting person was awarded 1,760 restricted stock units under the 2017 stock option and incentive plan. each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. the restricted stock units shall vest in equal 25% installments on february 15, 2021, february 15, 2022, february 15, 2023 and february 15, 2024, subject to continued service through such dates. the restricted stock units may be settled only by delivering shares of the issuer's common stock, and thus, the grant is being reported in table 1 as allowed per sec guidance. |
| f2 | this stock option award was issued pursuant to the issuer's 2017 stock option and incentive plan. the option vests in 48 equal monthly installments over a 4-year period following the vesting commencement date of 2/18/2020, subject to continued service through such dates. |
